SBX logo

SynBiotic SE Stock Price

DUSE:SBX Community·€13.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

SBX Share Price Performance

€2.01
-3.54 (-63.81%)
€2.01
-3.54 (-63.81%)
Price €2.01

SBX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

High growth potential with slight risk.

4 Risks
1 Reward

SynBiotic SE Key Details

€3.9m

Revenue

€2.4m

Cost of Revenue

€1.5m

Gross Profit

€12.1m

Other Expenses

-€10.6m

Earnings

Last Reported Earnings
Dec 31, 2023
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About SBX

Founded
2017
Employees
55
CEO
Daniel Kruse
WebsiteView website
www.synbiotic.com

SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names. The company was formerly known as Ledgertech SE and changed its name to SynBiotic SE. SynBiotic SE was founded in 2017 and is based in Munich, Germany.

Recent SBX News & Updates

Recent updates

No updates